- Filed
- Nov 14, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2023 · Nov 9, 2023 | 259.09M sh |
| Capex | Q3 2023 · Sep 30, 2023 | $0 |
| Capex | Q3 2023 · Sep 30, 2022 | $99K |
| Long Term Debt | Q3 2023 · Sep 30, 2023 | $0 |
| Long Term Debt | Q3 2023 · Dec 31, 2022 | $0 |
| Current Liabilities | Q3 2023 · Sep 30, 2023 | $144.18M |
| Current Liabilities | Q3 2023 · Dec 31, 2022 | $142.19M |
| Total Liabilities | Q3 2023 · Sep 30, 2023 | $146.94M |
| Total Liabilities | Q3 2023 · Dec 31, 2022 | $146.22M |
| Current Assets | Q3 2023 · Sep 30, 2023 | $5.71M |
| Current Assets | Q3 2023 · Dec 31, 2022 | $15.14M |
| Total Assets | Q3 2023 · Sep 30, 2023 | $9.47M |
| Total Assets | Q3 2023 · Dec 31, 2022 | $20.91M |
| Shares Diluted | Q3 2023 · Sep 30, 2022 | 259.09M sh |
| Shares Diluted | Q3 2023 · Sep 30, 2022 | 259.09M sh |
| Operating Cash Flow | Q3 2023 · Sep 30, 2022 | −$7.55M |
| Stockholders Equity | Q3 2023 · Sep 30, 2022 | −$121.96M |
| Stockholders Equity | Q3 2023 · Jun 30, 2022 | −$119.03M |
| Stockholders Equity | Q3 2023 · Mar 31, 2022 | −$116.81M |
| Stockholders Equity | Q3 2023 · Dec 31, 2021 | −$117.09M |
| Eps Diluted | Q3 2023 · Sep 30, 2022 | −$0.01 |
| Eps Diluted | Q3 2023 · Sep 30, 2022 | −$0.02 |
| Eps Basic | Q3 2023 · Sep 30, 2022 | −$0.01 |
| Eps Basic | Q3 2023 · Sep 30, 2022 | −$0.02 |
| Net Income | Q3 2023 · Sep 30, 2022 | −$2.93M |
| Net Income | Q3 2023 · Sep 30, 2022 | −$4.87M |
| Net Income | Q3 2023 · Jun 30, 2022 | −$2.22M |
| Net Income | Q3 2023 · Mar 31, 2022 | $276K |
| Operating Income restated | Q3 2023 · Sep 30, 2022 | −$917K |
| Operating Income restated | Q3 2023 · Sep 30, 2022 | −$748K |
| Gross Profit restated | Q3 2023 · Sep 30, 2022 | $1.89M |
| Gross Profit restated | Q3 2023 · Sep 30, 2022 | $6.4M |
| Cost Of Revenue restated | Q3 2023 · Sep 30, 2022 | $2.71M |
| Cost Of Revenue restated | Q3 2023 · Sep 30, 2022 | $7.87M |